Minimal dataset for quitlines: a best practice

H Sharon Campbell, Deborah Ossip-Klein, Linda Bailey, Jessie Saul, North American Quitline Consortium, H Sharon Campbell, Deborah Ossip-Klein, Linda Bailey, Jessie Saul, North American Quitline Consortium

Abstract

Objectives: This paper discusses the development of a minimal dataset (MDS) for tobacco cessation quitlines across North America. The goal was to create a standardised instrument and protocol that would allow for comparisons and pooling of data across quitlines for evaluation and research purposes. Principles of utilisation focused evaluation were followed to achieve consensus across diverse stakeholder groups in two countries.

Methods: The North American Quitline Consortium (NAQC) assembled a working group with representatives from quitline service providers, funders, evaluators and researchers from Canada and the United States. An extensive, iterative consultation process over two years led to consensus on the evaluation domains, indicators and specific items. Descriptive information on quitline service models, data collection protocols and methodological issues were addressed.

Results: The resulting minimal dataset (MDS) includes 15 items collected from eligible callers at intake and eight items collected from smokers participating in evaluation. Recommendations for selecting evaluation participants, length of follow-up and repeat callers were developed. Full MDS questions and technical documents are available on the NAQC website.

Conclusion: Adoption and implementation of the MDS occurred in the majority of North American quitlines by the end of 2006. Key success factors included a focus on utility and feasibility, a commitment to meeting multiple and varied needs, sensitivity to situational factors and investment in working interactively with stakeholders. The creation and implementation of a MDS across two countries is an important "first" in tobacco control which will help speed the creation of practice based evidence and facilitate practice based research.

References

    1. Stead L, Lancaster T, Perera R. Telephone counseling for smoking cessation. Cochrane Review. The Cochrane Library, Issue 2 2004
    1. Stead L F, Perera R, Lancaster T. A systematic review of interventions for smokers who contact quitlines. Tob Control 200716(Suppl)i3–i8.
    1. Ossip‐Klein D J, McIntosh S M. Quitlines in North America: evidence base and applications. Am J Med Sci 2003326201–205.
    1. Zhu S H, Anderson C M, Tedeschi G al Evidence of real‐world effectiveness of a telephone quitline for smokers. N Engl J Med 20023471087–1093.
    1. Ossip‐Klein D J, Giovino G A, Megahed al Effects of a smokers' hotline: results of a ten county self‐help trial. J Consult Clin Psychol 199159325–332.
    1. Tomson T, Helgason A R, Gilljam H. Quitline in smoking cessation: a cost‐effectiveness analysis. Int J Tech Assess in Health Care 200420469–474.
    1. Stephens T, Campbell S, Ghent A.Ontario smokers' helpline: a cost benefit analysis. Presented at the European Society for Research on Nicotine and Tobacco. Prague, Czech Republic, March 2005
    1. MCDS Australian national tobacco strategy, 2004–2009. Canberra: Department of Health and Ageing, 2005
    1. Fiore M, Croyle R, Curry al Preventing 3 million premature deaths and helping 5 million smokers quit: a national action plan for tobacco cessation. Am J Public Health 200494205–210.
    1. Centers for Disease Control and Prevention Telephone quitlines: a resource for development, implementation, and evaluation. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Final Edition, September, 2004
    1. Rogers E M.Diffusion of innovations. 5th ed. New York: Free Press, 2003
    1. North American Quitline Consortium Quitlines of North America and Europe 2006. Phoenix, AZ: NAQC, 2006
    1. Patton M Q.Utilization focused evaluation: the new century text. Thousand Oaks, CA: Sage, 1997
    1. Farkas A J, Pierce J P, Zhu S al Addiction versus stages of change models in predicting smoking cessation. Addiction. 1996;91:1271–80; discussion 1281–92.
    1. Carlson L E, Taenzer P, Koopmans al Predictive value of aspects of the Transtheoretical Model on smoking cessation in a community‐based, large‐group cognitive behavioral program. Addict Behav 200328725–740.
    1. Helgason A R, Tomson T, Lund K al Factors related to abstinence in a telephone helpline for smoking cessation. Eur J Public Health 200414306–310.
    1. NAQC Frequently Asked Questions about the MDS. 2005;
    1. Cummins S E, Bailey L, Campbell al Tobacco cessation quitlines in North America: a descriptive study. Tob Control 200716(Suppl)i9–15.
    1. Hughes J, Keely J P, Niaura R al Measures of abstinence from tobacco in clinical trials: issues and recommendations. Nic Tob Res 2003513–25.
    1. Pierce J P, Gilpin E A. A minimum 6‐month prolonged abstinence should be required for evaluating smoking cessation trials. Nic Tob Res 20035151–153.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться